Evaluation of the cardiac autonomic nervous system in spontaneously non- insulin-dependent diabetic rats by 123I-metaiodobenzylguanidine imaging

Annals of Nuclear Medicine

Volumn 13, Issue 1, 1999, Pages 19-26

  Togane, Yuko ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

123I MIBG; Autonomic nervous system; Cathecolamine; Diabetes mellitus; OLETF rats

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADRENALIN; CATECHOLAMINE; DOPAMINE; GLUCOSE; INSULIN; NORADRENALIN; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; EVALUATION; HEART INNERVATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SCINTILLATION CAMERA; STRAIN DIFFERENCE;

EID: 0033012061     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03165423     Document Type: Article

References (30)

1. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 67 (13): 1073-1078, 1991.
2. Galdelisi M, Anderson KM, Wilson PWF, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy. Am J Cardiol 68: 85-89, 1991.
3. Van Hoever KH, Factor SM. A comparison of the pathologic spectrum of hypertensive, diabetic, and hypertensive diabetic heart disease. Circulation 82: 848-855, 1990.
4. Bellavere F, Ferri M, Guariui L, Bax G, Piccoli A, Cardone C, et al. Prolonged QT period in diabetic autonomie neuropathy: a possible role in sudden cardiac death. Br Heart J 59: 379-383, 1988.
5. Saul JP, Rea RF, Eckberg DL. Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity. Am J Physiol 258: H713-H721, 1990.
6. 131I) iodobenzyl-guanidine. J Nucl Med 21: 349-353, 1980.
7. Hattori N, Tamaki N, Hayashi T, Masuda I, Kudoh T, Tateno M, et al. Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 37: 1985-1990, 1996.
8. 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45: 801-805, 1996.
9. Wakasugi S, Inoue M, Tazawa S. Assessment of adrenergic neuron function altered with progression heart failure. J Nucl Med 36: 2069-2074, 1995.
10. Schofer J, Spielmann R. Iodine-123 metaiodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 12: 1252-1258, 1988.
11. 123I-MIBG by polar map in patients with dilated cardiomyopathy. Nucl Med Commun 8: 219-229, 1997.
12. Merlet P, Valette H, Dubois RJ, Moyse D, Duboc D, Dove P: Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33: 471-477, 1992.
13. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41: 1422-1428, 1992.
14. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Hara T, et al. Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effects of anticoagulant. Eur J Pharmacol 313: 201-209, 1996.
15. Kosegawa I, Katayama S, Kikuchi C, Kashiwabara H, Negishi K, Ishii J, et al. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance. Hypertension Res 19: 37-41, 1996.
16. Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension 29: 728-735, 1997.
17. Das MW, O'Connell JW, Botvinick EH. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 79: 634-644, 1989.
18. Wieland DM, Brown LE, Rogers WL. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 22: 22-31, 1981.
19. Nakajo M. Iodine-131 metaiodobenzylguanidine intra- and extra-vesicular accumulation in the heart. J Nucl Med 27: 84-89, 1986.
20. Scisson JC, Wieland DM, Sherman P. Metaiodobenzylguanidine as an index of adrenergic nervous system integrity and function. J Nucl Med 28: 1620-1624, 1987.
21. Iwasaki T, Suzuki T, Tateno M. Dual-tracer autoradiography with thallium-201 and iodine-125-metaiodobenzyl-guanidine in experimental myocardial infarction of rat. J Nucl Med 37: 680-684, 1996.
22. Dubois EA, Kam KL, Aernous Somsen G, Boer GJ, de Bruin K, Batink HD, et al. Cardiac iodine-123-metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension. Eur J Nucl Med 23: 901-908, 1996.
23. 123I]metaiodobenzylguanidine. Diabetes 41: 1069-1075, 1992.
24. Lembo G, Napoli R, Capaldo B, Rendina V, Laccarino G, Volpe M, et al. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 90: 24-29, 1992.
25. Chidsey CA, Sonnenblic E. Norepinephrine stores and contractile force of papillary muscle from the failing human heart. Circulation 33: 43-51, 1966.
26. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 41: 233, 1978.
27. Christensen NJ. Catecholamines and diabetes mellitus. Diabetologia 16: 211-224, 1979.
28. Cryer PE, Silverberg AB, Santiago JV, Shan SD. Plasma catecholamines in diabetes. Am J Med 64: 407-416, 1978.
29. Cryer PE. Decreased sympathochromaffin activity in IDDM. Diabetes 38: 405-409, 1989.
30. Nishio Y, Kashiwagi A, Kida Y, Kodama M, Abe N, Saeki Y, et al. Deficiency of cardiac β-adrenergic receptor in streptozotocin-induced diabetic rats. Diabetes 37: 1181-1187, 1988.